查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386578

间质干细胞市场报告：2030 年趋势、预测与竞争分析

Mesenchymal Stem Cell Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

间质干细胞的发展趋势与预测

2030年，全球间间质干细胞市场预计将达到66亿美元，2024年至2030年的年复合成长率为13.1%。这个市场的主要驱动力是糖尿病、癌症和自体自体免疫疾病等慢性疾病的盛行率不断上升，再生医学的吸引力不断增强，以及利用间质干细胞创造创新治疗方法的目标。生物製药公司的研发工作正在迅速推进增加。全球间质干细胞市场的未来在疾病建模、药物研发发现和开发、干细胞库、组织工程和毒性研究市场方面前景广阔。

间质干细胞市场洞察

Lucintel注意到间质干细胞在临床使用中的强大安全实绩，间质干细胞的移植是一项突破，因为它们不太可能引发免疫反应并且具有免疫抑制特性。我们预测它将成为一种细胞为本治疗方法。

间质干细胞在预测期内将继续增长，因为目前美国正在进行临床试验，旨在评估其作为多种危及生命的疾病的潜在治疗选择的有效性和安全性。北美仍然是最大的地区。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球间间质干细胞市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球间间质干细胞市场趋势（2018-2023）与预测（2024-2030）
  • 按工作流程分類的全球间间质干细胞市场
    • 细胞采购与分离
    • 培养及冷冻保存
    • 差异化
    • 特性评价
  • 按类型分類的全球间间质干细胞市场
    • 自体的
    • 同种异体的
  • 全球间间质干细胞市场（依应用）
    • 疾病建模
    • 药物研发发现和发现
    • 干细胞库
    • 人体组织工程
    • 毒理学研究
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 按地区分類的全球间间质干细胞市场
  • 北美间间质干细胞市场
  • 欧洲间质干细胞市场
  • 亚太间间质干细胞市场
  • 其他区域间质干细胞市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 按工作流程分類的全球间间质干细胞市场成长机会
    • 全球间间质干细胞市场成长机会（按类型）
    • 全球间间质干细胞市场成长机会（依应用）
    • 全球间间质干细胞市场成长机会（按地区）
  • 全球间间质干细胞市场新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球间间质干细胞市场的产能
    • 全球间间质干细胞市场的合併、收购及合资企业
    • 认证和许可

第7章主要企业概况

  • Thermo Fisher Scientific
  • Cell Applications
  • Axol Biosciences
  • Cytori Therapeutics
  • STEMCELL Technologies
  • Cyagen Biosciences
  • Celprogen
  • BrainStorm Cell
  • Stemedica Cell Technologies
  • Merck
简介目录

Mesenchymal Stem Cell Trends and Forecast

The future of the global mesenchymal stem cell market looks promising with opportunities in the disease modelling, drug development & discovery, stem cell banking, tissue engineering, and toxicology study markets. The global mesenchymal stem cell market is expected to reach an estimated $6.6 billion by 2030 with a CAGR of 13.1% from 2024 to 2030. The major drivers for this market are rising incidence of chronic conditions including diabetes, cancer, and autoimmune illnesses, growing appeal of regenerative medicine, and surge in research and development efforts by biopharmaceutical firms to create innovative therapies utilizing mesenchymal stem cells.

A more than 150-page report is developed to help in your business decisions.

Mesenchymal Stem Cell by Segment

The study includes a forecast for the global mesenchymal stem cell by workflow, type, application, and region.

Mesenchymal Stem Cell Market by Workflow [Shipment Analysis by Value from 2018 to 2030]:

  • Cell Sourcing & Isolation
  • Culture & Cryopreservation
  • Differentiation
  • Characterization

Mesenchymal Stem Cell Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Autologous
  • Allogeneic

Mesenchymal Stem Cell Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Disease Modelling
  • Drug Development & Discovery
  • Stem Cell Banking
  • Tissue Engineering
  • Toxicology Studies
  • Others

Mesenchymal Stem Cell Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Mesenchymal Stem Cell Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies mesenchymal stem cell companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the mesenchymal stem cell companies profiled in this report include-

  • Thermo Fisher Scientific
  • Cell Applications
  • Axol Biosciences
  • Cytori Therapeutics
  • STEMCELL Technologies
  • Cyagen Biosciences
  • Celprogen
  • Brainstorm Cell
  • Stemedica Cell Technologies
  • Merck

Mesenchymal Stem Cell Market Insights

Lucintel forecasts that allogeneic will remain the larger segment over the forecast period due to strong safety track record of allogeneic mesenchymal stem cells in clinical use is noteworthy, and transplantation of allogeneic MSCs is poised to become a groundbreaking cell-based therapeutic method owing to its low potential for triggering immune responses and its immunosuppressive properties.

North America will remain the largest region over the forecast period because the significant volume of clinical trials is currently in progress within the United States, aimed at evaluating the effectiveness and safety of mesenchymal stem cells as a potential treatment option for various life-threatening diseases.

Features of the Global Mesenchymal Stem Cell Market

Market Size Estimates: Mesenchymal stem cell market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Mesenchymal stem cell market size by workflow, type, application, and region in terms of value ($B).

Regional Analysis: Mesenchymal stem cell market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different workflow, type, application, and regions for the mesenchymal stem cell market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the mesenchymal stem cell market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the mesenchymal stem cell market size?

Answer: The global mesenchymal stem cell market is expected to reach an estimated $6.6 billion by 2030.

Q.2 What is the growth forecast for mesenchymal stem cell market?

Answer: The global mesenchymal stem cell market is expected to grow with a CAGR of 13.1% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the mesenchymal stem cell market?

Answer: The major drivers for this market are rising incidence of chronic conditions including diabetes, cancer, and autoimmune illnesses, growing appeal of regenerative medicine, and surge in research and development efforts by biopharmaceutical firms to create innovative therapies utilizing mesenchymal stem cells.

Q4. What are the major segments for mesenchymal stem cell market?

Answer: The future of the global mesenchymal stem cell market looks promising with opportunities in the disease modelling, drug development & discovery, stem cell banking, tissue engineering, and toxicology study markets.

Q5. Who are the key mesenchymal stem cell market companies?

Answer: Some of the key mesenchymal stem cell companies are as follows:

  • Thermo Fisher Scientific
  • Cell Applications
  • Axol Biosciences
  • Cytori Therapeutics
  • STEMCELL Technologies
  • Cyagen Biosciences
  • Celprogen
  • Brainstorm Cell
  • Stemedica Cell Technologies
  • Merck

Q6. Which mesenchymal stem cell market segment will be the largest in future?

Answer: Lucintel forecasts that allogeneic will remain the larger segment over the forecast period due to strong safety track record of allogeneic mesenchymal stem cells in clinical use is noteworthy, and transplantation of allogeneic MSCs is poised to become a groundbreaking cell-based therapeutic method owing to its low potential for triggering immune responses and its immunosuppressive properties.

Q7. In mesenchymal stem cell market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period because the significant volume of clinical trials is currently in progress within the United States, aimed at evaluating the effectiveness and safety of mesenchymal stem cells as a potential treatment option for various life-threatening diseases.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the mesenchymal stem cell market by workflow (cell sourcing & isolation, culture & cryopreservation, differentiation, and characterization), type (autologous and allogeneic), application (disease modelling, drug development & discovery, stem cell banking, tissue engineering, toxicology studies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Mesenchymal Stem Cell Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Mesenchymal Stem Cell Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Mesenchymal Stem Cell Market by Workflow
    • 3.3.1: Cell Sourcing & Isolation
    • 3.3.2: Culture & Cryopreservation
    • 3.3.3: Differentiation
    • 3.3.4: Characterization
  • 3.4: Global Mesenchymal Stem Cell Market by Type
    • 3.4.1: Autologous
    • 3.4.2: Allogeneic
  • 3.5: Global Mesenchymal Stem Cell Market by Application
    • 3.5.1: Disease Modelling
    • 3.5.2: Drug Development & Discovery
    • 3.5.3: Stem Cell Banking
    • 3.5.4: Tissue Engineering
    • 3.5.5: Toxicology Studies
    • 3.5.6: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Mesenchymal Stem Cell Market by Region
  • 4.2: North American Mesenchymal Stem Cell Market
    • 4.2.1: North American Mesenchymal Stem Cell Market by Type: Autologous and Allogeneic
    • 4.2.2: North American Mesenchymal Stem Cell Market by Application: Disease Modelling, Drug Development & Discovery, Stem Cell Banking, Tissue Engineering, Toxicology Studies, and Others
  • 4.3: European Mesenchymal Stem Cell Market
    • 4.3.1: European Mesenchymal Stem Cell Market by Type: Autologous and Allogeneic
    • 4.3.2: European Mesenchymal Stem Cell Market by Application: Disease Modelling, Drug Development & Discovery, Stem Cell Banking, Tissue Engineering, Toxicology Studies, and Others
  • 4.4: APAC Mesenchymal Stem Cell Market
    • 4.4.1: APAC Mesenchymal Stem Cell Market by Type: Autologous and Allogeneic
    • 4.4.2: APAC Mesenchymal Stem Cell Market by Application: Disease Modelling, Drug Development & Discovery, Stem Cell Banking, Tissue Engineering, Toxicology Studies, and Others
  • 4.5: ROW Mesenchymal Stem Cell Market
    • 4.5.1: ROW Mesenchymal Stem Cell Market by Type: Autologous and Allogeneic
    • 4.5.2: ROW Mesenchymal Stem Cell Market by Application: Disease Modelling, Drug Development & Discovery, Stem Cell Banking, Tissue Engineering, Toxicology Studies, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Mesenchymal Stem Cell Market by Workflow
    • 6.1.2: Growth Opportunities for the Global Mesenchymal Stem Cell Market by Type
    • 6.1.3: Growth Opportunities for the Global Mesenchymal Stem Cell Market by Application
    • 6.1.4: Growth Opportunities for the Global Mesenchymal Stem Cell Market by Region
  • 6.2: Emerging Trends in the Global Mesenchymal Stem Cell Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Mesenchymal Stem Cell Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Mesenchymal Stem Cell Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: Cell Applications
  • 7.3: Axol Biosciences
  • 7.4: Cytori Therapeutics
  • 7.5: STEMCELL Technologies
  • 7.6: Cyagen Biosciences
  • 7.7: Celprogen
  • 7.8: BrainStorm Cell
  • 7.9: Stemedica Cell Technologies
  • 7.10: Merck